MRI study to prepare for adaptive MRI-guided radiation of prostate carcinoma.

MRI study to prepare for adaptive MRI-guided radiation of prostate carcinoma. - MRL-PCa

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49848

Enrollment

Registered

2021-01-12

Start date

2020-10-01

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Low to intermediate risk prostate carcinoma; scheduled for external beam radiation therapy; meet all MRI safety criteria; written informed consent; over 18 years of age

Exclusion criteria

Exclusion criteria: Transurethral resection of the prostate (TURP) in the last 3 months; hip prosthesis

Design outcomes

Primary

Measure	Time frame
Dose parameters D2cc of the bladder and prostate, which are an indication for toxicity.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results